BLFS vs XYL · rev $56.0M vs P/E 27, rev $4.46B
BioLife Solutions Inc (BLFS) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
BioLife Solutions Inc (BLFS) is a medical instruments & supplies company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported BLFS revenue for 2026-06-30 was $56.0M. Net income was $46.3M. BLFS currently screens at market cap $1.05B.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
BLFS currently screens at market cap $1.05B. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the BLFS and XYL stock pages for the full models.
Not investment advice.